ストックスクリーナーアプリを入手
0.00
100.00%
-84.95
Crinetics Pharmaceuticals Inc (CRNX) 最新ニュース
Vertex Pharmaceuticals Maps Growth Beyond CF at Cantor Conference - Yahoo Finance
Vertex Pharmaceuticals Incorporated (VRTX): Crinetics Acquisition Creates a New Growth Engine Beyond Cystic Fibrosis - Yahoo Finance
Crinetics Pharmaceuticals, Inc. SEC Filing (Sep 11, 2026) - Stock Titan
Vertex Pharma stock falls as market digests Crinetics deal and valuation risks - ad-hoc-news.de
Vertex Pharma stock heads into the open after a 3.1 percent drop - ad-hoc-news.de
CRNXCrinetics Pharmaceuticals Inc Revenue Breakdown - Finviz
Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.06% on Sep 8: What Signal Does It Send? - TradingKey
Vertex Shares Fall as Investors Digest Crinetics Acquisition and Related Financing Plans - Moomoo
Vertex shares fall as investors digest Crinetics acquisition and related financing plans - Quiver Quantitative
Crinetics Acquisition Creates A ‘Fifth Commercial Pillar’ For Vertex, Says Analyst – Why HC Wainwright Sees A 24% Upside Potential In VRTX Stock - Stocktwits
Enterprise value to EBITDA forward of Crinetics Pharmaceuticals Inc – SWB:6Z4 - TradingView
Vertex sees over $5 billion peak sales from Crinetics assets - scanx.trade
Ademi LLP investigates Crinetics sale to Vertex over fair price - scanx.trade
Crinetics Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC - The National Law Review
Crinetics Pharmaceuticals, Inc.(NasdaqGS:CRNX) dropped from S&P Pharmaceuticals Select Industry Index - marketscreener.com
Crinetics Pharmaceuticals, Inc.(NasdaqGS: CRNX) dropped from S&P Global BMI Index - marketscreener.com
Crinetics Pharmaceuticals, Inc.(NasdaqGS: CRNX) dropped from S&P TMI Index - marketscreener.com
CRNX Suspended by Cantor Fitzgerald -- Rating Maintained at Neut - GuruFocus
Crinetics Pharmaceuticals, Inc.(NasdaqGS: CRNX) dropped from Russell 2000 Growth Index - marketscreener.com
News On Crinetics Pharmaceuticals Inc. (CRNX) Now Under VRTX - Moomoo
$85-per-share buyout shows how Crinetics (CRNX) insiders were paid in Vertex deal - Stock Titan
Vertex deal cashes out Crinetics (NASDAQ: CRNX) director’s stock and options - Stock Titan
Crinetics (NASDAQ: CRNX) director’s stock and options converted to $85 cash in Vertex deal - Stock Titan
Vertex deal cancels Crinetics (NASDAQ: CRNX) director's shares and options - Stock Titan
Vertex buyout pays Crinetics (CRNX) insider in cash, but his options fared very differently - Stock Titan
Vertex buyout pays Crinetics (NASDAQ: CRNX) director for stock and options - Stock Titan
Crinetics (NASDAQ: CRNX) director’s stock, options and RSUs all vest and turn to cash in Vertex buyout - Stock Titan
Crinetics (NASDAQ: CRNX) CCO awards vest, then are cashed out or wiped in $85-a-share Vertex merger - Stock Titan
Takeover hands Crinetics (CRNX) science chief an $85-a-share cash exit - Stock Titan
Vertex’s $85 deal cashes out Crinetics (NASDAQ: CRNX) awards - Stock Titan
Crinetics (CRNX) shareholders receive $85 per share as Vertex takeover closes - Stock Titan
Crinetics Pharmaceuticals, Inc. SEC Filing (Sep 1, 2026) - Stock Titan
Vertex Completes $10 Billion Crinetics Acquisition, Adding Rare Endocrine Growth Platform - Yahoo Finance
Vertex Pharmaceuticals Completes $10 Billion Acquisition of Crinetics Pharmaceuticals at $85 Per Share - Kalkine Media
Vertex Names Jonathan Poole Finance Chief as Crinetics Buy Closes - marketscreener.com
Vertex Pharmaceuticals Closes Crinetics Pharmaceuticals Acquisition - marketscreener.com
Nasdaq starts delisting Crinetics (NASDAQ: CRNX) shares and ends its Section 12(b) listing - Stock Titan
Crinetics Pharmaceuticals Ends ATM Sales Agreement With SVB Leerink, Cantor Following Vertex Merger - TradingView
Crinetics Pharmaceuticals (NASDAQ: CRNX) exits in $10B Vertex deal and what shareholders are getting - Stock Titan
Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team - Business Wire
Crinetics Pharmaceuticals, Inc.(NasdaqGS: CRNX) dropped from NASDAQ Composite Index - marketscreener.com
Neurocrine's Crenessity Gains Ground in CAH: How Far Can Sales Go? - Eastern Progress
Shareholder approval clears way for Crinetics (NASDAQ: CRNX) sale to Vertex - Stock Titan
Crinetics Pharmaceuticals held special shareholder meeting on merger proposal vote - Bitget
Crinetics Pharmaceuticals stock hits all-time high at 84.8 USD By Investing.com - Investing.com Nigeria
Crinetics Pharmaceuticals stock hits all-time high at 84.8 USD - investing.com
The Zacks Analyst Blog Highlights Amgen, Crinetics, FBT, BBH and BBP - Yahoo Finance
Crinetics Pharmaceuticals (NASDAQ:CRNX) Sees Large Volume IncreaseWhat's Next? - MarketBeat
TD Cowen and Evercore ISI downgrade Crinetics Pharmaceuticals - scanx.trade
Bet on These Biotech ETFs as Innovation Drives Market-Beating Growth - TradingView
Crinetics (CRNX) Trading: Stays Close to Unchanged at $84.69 in the Latest Reading; Price Levels - Vinanet
Crinetics Pharmaceuticals to supplement proxy after shareholder suits ahead of $85-per-share Vertex merger - TradingView
Crinetics (CRNX) projects $1B+ 2030 revenue for Vertex deal - Stock Titan
CRNX (Crinetics Pharmaceuticals) EV-to-OCF : -18.54 (As of Aug. 19, 2026) - GuruFocus
Crinetics Pharmaceuticals (CRNX) Stock Looks Overvalued Despite Strong 3 Year Returns - Sahm
Rice Hall James & Associates LLC Takes $7.35 Million Position in Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
Crinetics Pharmaceuticals (NASDAQ:CRNX) Reaches New 52-Week HighTime to Buy? - MarketBeat
Crinetics Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Crinetics Pharmaceuticals, Inc.CRNX - marketscreener.com
Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even More - AOL.com
Bank of America Corp DE Sells 85,189 Shares of Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
Quantinno Capital Management LP Buys 24,878 Shares of Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
Why Did CRNX, D, BCRX Stocks Surge To 52-Week Highs Today? - Stocktwits
Vertex-Crinetics pharma merger cleared in US, Germany, Austria, Australia - MLex
Form 8K Crinetics Pharmaceuticals Inc For: 14 August By Investing.com - Investing.com Australia
Crinetics Pharmaceuticals merger with Vertex Pharmaceuticals advances after regulatory clearances - Investing.com
0.24%
1.67%
大文字化:
|
ボリューム (24 時間):